How to buy McKesson Corporation (MCK) shares in Australia

Learn how to easily invest in McKesson Corporation shares.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

McKesson Corporation (MCK) is a leading medical distribution business with stocks listed in the US. It opened the day at US$248.23 after a previous close of US$248.9. During the day the price has varied from a low of USD248.23 to a high of USD250.94. The latest price was USD248.57 (25 minute delay). McKesson Corporation is listed on the NYSE. All prices are listed in US Dollars.

How to buy shares in McKesson Corporation

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for McKesson Corporation. Find the share by name or ticker symbol: MCK. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until McKesson Corporation reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$248.9, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of McKesson Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of McKesson Corporation. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

McKesson Corporation stock price (NYSE:MCK)

Use our graph to track the performance of MCK stocks over time.

McKesson Corporation shares at a glance

Information last updated 2021-12-31.
OpenUS$248.23
HighUS$250.94
LowUS$248.23
CloseUS$248.57
Previous closeUS$248.9
Change US$-0.33
Change % -0.1326%
Volume 460,623
Information last updated 2022-01-17.
52-week rangeUS$167.8075 - US$256.85
50-day moving average US$232.9422
200-day moving average US$206.6454
Target priceUS$280.46
PE ratio N/A
Dividend yield US$1.73 (0.74%)
Earnings per share (TTM) US$-30.589

Where to buy McKesson Corporation stock

Name Product Standard brokerage for US shares Currency conversion fee Markets
eToro (global stocks)
US$0
50 pips (US$0.50 for every AU$100 exchanged)
Global shares, US shares, ETFs
Zero brokerage share trading on US, Hong Kong and European stocks with trades as low as $50.
Note: This broker offers CFDs which are volatile investment products and most clients lose money trading CFDs with this provider.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
US$0
0.70%
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Superhero share trading
US$0
50 pips (US$0.50 for every AU$100 exchanged)
ASX shares, US shares, ETFs
Earn up to 15,000 Qantas frequent flyer points when you transfer an exisiting balance or trade. Offer valid for all new and existing Superhero members until 28 February.
Pay zero brokerage on US stocks and all ETFs and just $5 (flat fee) to trade Australian shares from your mobile or desktop.
CMC Markets Invest
US$0
0.60%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
Saxo Capital Markets (Classic account)
US$4
1%
ASX shares, Global shares, ETFs
Access 19,000+ stocks on 40+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
SelfWealth (Basic account)
US$9.5
0.60%
ASX shares, US shares
Trade ASX and US shares for a flat fee of $9.50, regardless of the trade size.
New customers receive free access to Community Insights with SelfWealth Premium for the first 90 days. Follow other investors and benchmark your portfolio performance.
loading

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy McKesson Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

McKesson Corporation share growth calculator

US$

Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.

McKesson Corporation price performance over time

Historical closes compared with the last close of $248.57

1 week (2022-01-12) -2.38%
1 month (2021-12-21) 5.29%
6 months (2021-07-22) 24.89%
1 year (2021-01-22) 34.35%
2 years (2020-01-22) 59.61%
3 years (2019-01-22) 97.48%
5 years (2017-01-20) 65.40%

Is McKesson Corporation under- or over-valued?

Valuing McKesson Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of McKesson Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

McKesson Corporation's PEG ratio

McKesson Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 26.752. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into McKesson Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

McKesson Corporation's EBITDA

McKesson Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$4.1 billion (£3 billion).

The EBITDA is a measure of a McKesson Corporation's overall financial performance and is widely used to measure a its profitability.

McKesson Corporation financials

Revenue TTM US$251 billion
Operating margin TTM 1.29%
Gross profit TTM US$12 billion
Return on assets TTM 3.23%
Return on equity TTM -127%
Profit margin -1.92%
Book value 36.683
Market capitalisation US$39.2 billion

TTM: trailing 12 months

McKesson Corporation's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like McKesson Corporation.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

McKesson Corporation's total ESG risk score

Total ESG risk: 23.8

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and McKesson Corporation's overall score of 23.8 (as at 12/31/2018) is pretty good – landing it in it in the 26th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like McKesson Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

McKesson Corporation's environmental score

Environmental score: 9.12/100

McKesson Corporation's environmental score of 9.12 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that McKesson Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

McKesson Corporation's social score

Social score: 17.15/100

McKesson Corporation's social score of 17.15 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that McKesson Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

McKesson Corporation's governance score

Governance score: 12.53/100

McKesson Corporation's governance score puts it squarely in the 8th percentile of companies rated in the same sector. That could suggest that McKesson Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

McKesson Corporation's controversy score

Controversy score: 4/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. McKesson Corporation scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that McKesson Corporation has a damaged public profile.

Environmental, social, and governance (ESG) summary

McKesson Corporation was last rated for ESG on: 2019-01-01.

Total ESG score 23.8
Total ESG percentile 26.02
Environmental score 9.12
Environmental score percentile 8
Social score 17.15
Social score percentile 8
Governance score 12.53
Governance score percentile 8
Level of controversy 4

McKesson Corporation share dividends

8%

Dividend payout ratio: 8.33% of net profits

Recently McKesson Corporation has paid out, on average, around 8.33% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.74% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), McKesson Corporation shareholders could enjoy a 0.74% return on their shares, in the form of dividend payments. In McKesson Corporation's case, that would currently equate to about $1.73 per share.

While McKesson Corporation's payout ratio might seem low, this can signify that McKesson Corporation is investing more in its future growth.

McKesson Corporation's most recent dividend payout was on 2 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 29 November 2021 (the "ex-dividend date").

Have McKesson Corporation's shares ever split?

McKesson Corporation's shares were split on a 2:1 basis on 4 January 1998. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your McKesson Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for McKesson Corporation shares which in turn could have impacted McKesson Corporation's share price.

McKesson Corporation share price volatility

Over the last 12 months, McKesson Corporation's shares have ranged in value from as little as US$167.8075 up to US$256.85. A popular way to gauge a stock's volatility is its "beta".

MCK.US volatility(beta: 0.78)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while McKesson Corporation's is 0.7831. This would suggest that McKesson Corporation's shares are less volatile than average (for this exchange).

McKesson Corporation overview

McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site